Skip to main content
Erschienen in: Endocrine 1/2024

29.11.2023 | Original Article

Re-assessment of the close relationship between serum FSH levels and semen quality: a retrospective cohort study of 11,929 Chinese men

verfasst von: Wei-Kang Chen, Jing-Ping Li, Feng-Bin Zhang, Zhong-Yan Liang, Le-Jun Li, Jing-Gen Wu

Erschienen in: Endocrine | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To establish a medically valuable normal reference interval of follicle-stimulating hormone (FSH) levels in males with normal semen and to assess the predictive value of FSH in males exhibiting semen abnormalities.

Methods

The study involved male patients who underwent their initial serum sex hormone test and semen test between October 2013 and June 2023. The reference interval was identified as the 95% confidence interval (CI) of FSH values in the patients with normal semen parameters. Then, in the total study population, receiver operating characteristic (ROC) curves were performed to evaluate the discriminatory ability of FSH for oligozoospermia and non-obstructive azoospermia (NOA). Besides, multivariable logistic regression was performed to investigate the association of FSH with oligozoospermia and NOA adjusted by age.

Results

A total of 11,929 patients were finally enrolled in the study. The normal reference interval of FSH ranged from 1.70 IU/L to 7.60 IU/L (median: 3.98 IU/L) based on 4595 patients with normal semen routine parameters. In the total patients, ROC curves showed FSH to have a “fair” discriminatory ability for oligozoospermia (area under receiver operating characteristic curve (AUC) 0.747, threshold 7.32 IU/L, accuracy 0.734, positive predictive value (PPV) 0.754, negative predictive value (NPV) 0.726), while ROC curves showed FSH to have a “excellent” discriminatory ability for NOA (AUC: 0.921, threshold 10.18 IU/L, accuracy 0.903, PPV 0.593, NPV 0.972). Besides, multivariable logistic regression showed that FSH ≥ 7.32 IU/L was associated with a 8.51-fold increase in the risk of oligozoospermia adjusted by age, while FSH ≥ 10.18 IU/L was associated with a 38.93-fold increase in the risk of NOA.

Conclusions

Our findings indicated that the reference interval for FSH in males with normal semen was 1.70–7.60 IU/L and found that FSH was capable of effectively discerning oligospermia and NOA.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat E. Nieschlag, M. Simoni, J. Gromoll et al. Role of FSH in the regulation of spermatogenesis: clinical aspects. Clin. Endocrinol. 51, 139–146 (1999)CrossRef E. Nieschlag, M. Simoni, J. Gromoll et al. Role of FSH in the regulation of spermatogenesis: clinical aspects. Clin. Endocrinol. 51, 139–146 (1999)CrossRef
3.
Zurück zum Zitat P.N. Schlegel, M. Sigman, B. Collura et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. Fertil. Steril. 115, 54–61 (2021)CrossRefPubMed P.N. Schlegel, M. Sigman, B. Collura et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. Fertil. Steril. 115, 54–61 (2021)CrossRefPubMed
4.
Zurück zum Zitat A.F. Morrow, H.W. Baker, H.G. Burger, Different testosterone and LH relationships in infertile men. J. Androl. 7(5), 310–315 (1986)CrossRefPubMed A.F. Morrow, H.W. Baker, H.G. Burger, Different testosterone and LH relationships in infertile men. J. Androl. 7(5), 310–315 (1986)CrossRefPubMed
5.
Zurück zum Zitat T.K. Jensen, A.-M. Andersson, N.H. Hjollund et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J. Clin. Endocrinol. Metab. 82, 4059–4063 (1997)PubMed T.K. Jensen, A.-M. Andersson, N.H. Hjollund et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J. Clin. Endocrinol. Metab. 82, 4059–4063 (1997)PubMed
6.
Zurück zum Zitat J. Gordetsky, E. van Wijngaarden, J. O’Brien, Redefining abnormal follicle-stimulating hormone in the male infertility population. BJU Int 110(4), 568–572 (2012)CrossRefPubMed J. Gordetsky, E. van Wijngaarden, J. O’Brien, Redefining abnormal follicle-stimulating hormone in the male infertility population. BJU Int 110(4), 568–572 (2012)CrossRefPubMed
7.
Zurück zum Zitat M. Ozkaya, U. Oztekin, M. Caniklioglu et al. Re-determination of upper reference range of follicular stimulating hormone in infertile men. Syst. Biol. Reprod. Med 66(5), 329–336 (2020)CrossRefPubMed M. Ozkaya, U. Oztekin, M. Caniklioglu et al. Re-determination of upper reference range of follicular stimulating hormone in infertile men. Syst. Biol. Reprod. Med 66(5), 329–336 (2020)CrossRefPubMed
8.
Zurück zum Zitat A. Schoor Richard, S. Elhanbly, C.S. Niederberger et al. The role of testicular biopsy in the modern management of male infertility. J. Urol. 167, 197–200 (2002)CrossRefPubMed A. Schoor Richard, S. Elhanbly, C.S. Niederberger et al. The role of testicular biopsy in the modern management of male infertility. J. Urol. 167, 197–200 (2002)CrossRefPubMed
9.
Zurück zum Zitat A. Basukarno, P. Birowo, N. Rasyid, Cut-off value of testosterone and FSH level in patient with azoospermia. KnE Med. 1, 145–152 (2016).CrossRef A. Basukarno, P. Birowo, N. Rasyid, Cut-off value of testosterone and FSH level in patient with azoospermia. KnE Med. 1, 145–152 (2016).CrossRef
10.
Zurück zum Zitat J.P. Li, C.Q. Du, Z.B. Liu et al. Development and validation predictive models of sperm retrieval for azoospermic men undergoing testicular sperm aspiration: a multicentre, retrospective, cohort study. J. Assist Reprod. Genet 39(8), 1779–1787 (2022)CrossRefPubMedPubMedCentral J.P. Li, C.Q. Du, Z.B. Liu et al. Development and validation predictive models of sperm retrieval for azoospermic men undergoing testicular sperm aspiration: a multicentre, retrospective, cohort study. J. Assist Reprod. Genet 39(8), 1779–1787 (2022)CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat J.D. Meeker, L. Godfrey-Bailey, R. Hauser, Relationships between serum hormone levels and semen quality among men from an infertility clinic. J. Androl. 28, 397–406 (2007)CrossRefPubMed J.D. Meeker, L. Godfrey-Bailey, R. Hauser, Relationships between serum hormone levels and semen quality among men from an infertility clinic. J. Androl. 28, 397–406 (2007)CrossRefPubMed
12.
Zurück zum Zitat World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th ed. (World Health Organization, Geneva, 2010). World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th ed. (World Health Organization, Geneva, 2010).
13.
Zurück zum Zitat E. Weine, M.S. McPeek, M. Abney, Application of equal local levels to improve Q-Q plot testing bands with R package qqconf. J. Stat. Softw. 106(10), 10 (2023)CrossRefPubMedPubMedCentral E. Weine, M.S. McPeek, M. Abney, Application of equal local levels to improve Q-Q plot testing bands with R package qqconf. J. Stat. Softw. 106(10), 10 (2023)CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat K.H. Yuan, W. Chan, P.M. Bentler, Robust transformation with applications to structural equation modelling. Br. J. Math. Stat. Psychol. 53, 31–50 (2000)CrossRefPubMed K.H. Yuan, W. Chan, P.M. Bentler, Robust transformation with applications to structural equation modelling. Br. J. Math. Stat. Psychol. 53, 31–50 (2000)CrossRefPubMed
15.
Zurück zum Zitat F.F. Pasqualotto, B.P. Sobreiro, J. Hallak et al. Sperm concentration and normal sperm morphology decrease and follicle-stimulating hormone level increases with age. BJU Int. 96(7), 1087–1091 (2005)CrossRefPubMed F.F. Pasqualotto, B.P. Sobreiro, J. Hallak et al. Sperm concentration and normal sperm morphology decrease and follicle-stimulating hormone level increases with age. BJU Int. 96(7), 1087–1091 (2005)CrossRefPubMed
16.
Zurück zum Zitat S. Yu, L. Qiu, M. Liu et al. Establishing reference intervals for sex hormones and SHBG in apparently healthy Chinese adult men based on a multicenter study. Clin. Chem. Lab Med 56(7), 1152–1160 (2018)CrossRefPubMed S. Yu, L. Qiu, M. Liu et al. Establishing reference intervals for sex hormones and SHBG in apparently healthy Chinese adult men based on a multicenter study. Clin. Chem. Lab Med 56(7), 1152–1160 (2018)CrossRefPubMed
17.
Zurück zum Zitat R.J. Fantus, J.S. Lin, C. Chang et al. Compensated hypospermatogenesis: elevated follicle-stimulating hormone predicts decline in semen parameters among men with normal index semen analysis. Urology 174, 99–103 (2023)CrossRefPubMed R.J. Fantus, J.S. Lin, C. Chang et al. Compensated hypospermatogenesis: elevated follicle-stimulating hormone predicts decline in semen parameters among men with normal index semen analysis. Urology 174, 99–103 (2023)CrossRefPubMed
18.
Zurück zum Zitat WHO. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple (Cambridge University Press, Cambridge, 2000). WHO. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple (Cambridge University Press, Cambridge, 2000).
19.
Zurück zum Zitat M. Simoni, G. Brigante, V. Rochira et al. Prospects for FSH treatment of male infertility. J. Clin. Endocrinol. Metab. 105, dgaa243 (2020)CrossRefPubMed M. Simoni, G. Brigante, V. Rochira et al. Prospects for FSH treatment of male infertility. J. Clin. Endocrinol. Metab. 105, dgaa243 (2020)CrossRefPubMed
Metadaten
Titel
Re-assessment of the close relationship between serum FSH levels and semen quality: a retrospective cohort study of 11,929 Chinese men
verfasst von
Wei-Kang Chen
Jing-Ping Li
Feng-Bin Zhang
Zhong-Yan Liang
Le-Jun Li
Jing-Gen Wu
Publikationsdatum
29.11.2023
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2024
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03617-y

Weitere Artikel der Ausgabe 1/2024

Endocrine 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.